Skip to main content
Log in

Genotype testing at HIV diagnosis not cost effective in USA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2018 US dollars

  2. integrase strand inhibitors

Reference

  • Hyle EP, et al. Clinical impact and cost-effectiveness of genotype testing at HIV diagnosis in the United States. Clinical Infectious Diseases : 4 May 2019. Available from: URL: http://doi.org/10.1093/cid/ciz372

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Genotype testing at HIV diagnosis not cost effective in USA. PharmacoEcon Outcomes News 828, 19 (2019). https://doi.org/10.1007/s40274-019-5893-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5893-7

Navigation